Clinical characteristics of COVID-19 in pregnancy: analysis of nine cases
10.3760/cma.j.cn113903-20200216-00117
- VernacularTitle: 妊娠合并新型冠状病毒肺炎9例临床分析
- Author:
Di LEI
1
;
Chen WANG
2
;
Chunyan LI
1
;
Congcong FANG
3
;
Wenbing YANG
1
;
Biheng CHEN
1
;
Min WEI
1
;
Xiaoyu XU
1
;
Huixia YANG
2
;
Suqing WANG
4
;
Cuifang FAN
1
Author Information
1. Department of Obstetrics, Renmin Hospital of Wuhan University, Wuhan 430060, China
2. Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
3. Department of Pediatrics, Renmin Hospital of Wuhan University, Wuhan 430060, China
4. Department of Nutrition and Food Hygiene, School of Health Sciences, Wuhan University, Wuhan 430060, China
- Publication Type:Journal Article
- Keywords:
Coronavirus infections;
COVID-19;
Pneumonia, viral;
Pregnancy, vertical transmission
- From:
Chinese Journal of Perinatal Medicine
2020;23(3):225-231
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical characteristics and pregnant outcomes of gravidae with COVID-19. Methods This study involved nine gravidae with COVID-19 admitted to the Renmin Hospital of Wuhan University from January 22 to February 1, 2020. Their clinical data, including epidemiological history, clinical symptoms, laboratory examinations, chest CT, treatment, delivery mode, and pregnancy outcomes, were analyzed retrospectively. Specimens of maternal vaginal swab were collected in six pregnant women, and the specimens of amniotic fluid, cord blood, neonatal throat swab and breast milk samples were collected in four pregnant women who had a delivery during our study. All samples were tested for the existence of COVID-19. Descriptive analysis was applied in this study. Results (1) Among the nine cases, five were admitted in the third trimester and four in the second trimester. The median incubation period of COVID-19 was 8 (1-14) d. Fever was presented in all cases on admission, and the other commonly seen symptoms were cough (seven cases) and diarrhea (five cases). Other signs and symptoms were also reported, including shortness of breath, myalgia and fatigue (four cases in each), nasal obstruction, pharyngalgia, chest pain, and headache/dizziness (three cases in each), rash (two cases), and chills and expectoration (one case in each). The most common laboratory abnormalities were a decreased number of lymphocytes (seven cases) and elevated C-reactive protein (six cases). Chest CT scans were performed in seven women, and all showed patchy areas or ground-glass opacity in both lungs. Oligohydramnios was detected in only one case at 37 +5 weeks, which was 7 d after the diagnosis of COVID-19. (2) All nine cases received empiric antibiotic and antiviral therapy with Chinese medicine as adjuvant treatment. Eight patients required oxygen inhalation, and eight were treated with glucocorticoid. Six cases received immunotherapy. (3) Four of the nine cases had delivered, including three cesarean sections and one spontaneous vaginal preterm birth after premature rupture of membranes, and the mother was transferred to the intensive care unit 2 d after delivery due to acute respiratory distress syndrome. One case was terminated at 26 gestational weeks. Of the four neonates, there were two term and two premature babies, and one preterm baby was small-for-gestational-age. No neonatal asphyxia was observed. Serial real-time quantitative reverse transcription-polymerase chain reaction showed negative results in the detection of 2019-novel coronavirus in all samples obtained from amniotic fluid, umbilical cord blood, neonatal nasopharynx, breast milk, and vagina. Maternal conditions were all stable in all cases, including the four continuing pregnancy, and the terminated ones, except the case mentioned above. Conclusions There is no distinguishable clinical feature between pregnant and non-pregnant COVID-19 patients. So far, there is no evidence for vertical transmission or worsening perinatal outcome in mothers and babies.
